Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 30, 2022 08:00 ET | Source: Genetic Technologies Ltd

GENE Momentum building - a year in review

MELBOURNE, Australia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in guideline driven genomics-based tests in health,...
July 28, 2022 08:00 ET | Source: Genetic Technologies Ltd

Gene achieves key milestones and growth

MELBOURNE, Australia, July 28, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
July 18, 2022 08:00 ET | Source: Genetic Technologies Ltd

GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians

MELBOURNE, Australia, July 18, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
July 14, 2022 08:00 ET | Source: Genetic Technologies Ltd

Completion of AffinityDNA Acquisition expanding global direct-to-consumer business

MELBOURNE, Australia, July 14, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
July 05, 2022 08:00 ET | Source: Genetic Technologies Ltd

EasyDNA expands Indian and European markets; launching NIPT, Carrier testing and DNA storage

MELBOURNE, Australia, July 05, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
July 01, 2022 08:00 ET | Source: Genetic Technologies Ltd

GeneType Risk Assessment Test onboarding in 16 clinics

MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
June 16, 2022 08:00 ET | Source: Genetic Technologies Ltd

Transformational Pathway to US Payer System; Attributing US$1.4 Billion Health and Economic Benefit from geneType Breast Cancer Risk Assessment Test

MELBOURNE, Australia, June 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
May 16, 2022 09:00 ET | Source: Genetic Technologies Ltd

Acquisition of global direct to consumer ecommerce business

MELBOURNE, Australia, May 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
April 08, 2022 08:00 ET | Source: Genetic Technologies Ltd

Genetic Technologies drives leadership in precision medicine with Multi-Risk Test

MELBOURNE, Australia, April 08, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG) (“GENE” or the “Company”), a global leader in genomics-based tests in health, wellness...
February 23, 2022 08:00 ET | Source: Genetic Technologies Ltd

US Patent Office Grants Patent for COVID-19 Risk Test

MELBOURNE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right